# Chinese Medicine for Patients With Psoriasis

> **NCT05295979** · PHASE2 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 60 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Inflammatory skin disease formula
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05295979
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-20
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05295979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05295979, "Chinese Medicine for Patients With Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05295979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*